Myriad Genetics Inc (NASDAQ:MYGN)

27.37
Delayed Data
As of May 14
 +1.69 / +6.58%
Today’s Change
10.54
Today|||52-Week Range
33.97
+38.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
AssetsCash110.9M93.3M90.6M84.9M
 
 
 
 
 
Short Term Investment Cash13.5M-17.6M-2.7M-5.7M
 
 
 
 
 
Cash & Short Term Investments180.6M167.5M165.4M149.7M
 
 
 
 
 
 
ReceivablesReceivables102.1M123.4M122.5M147.0M
 
 
 
 
 
 
InventoriesInventories34.3M35.9M33.3M31.9M
 
 
 
 
 
 
Current AssetsPrepaid Expenses9.4M15.1M15.6M14.3M
 
 
 
 
 
Current Assets326.4M341.9M336.8M342.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross157.1M164.5M165.4M167.8M
 
 
 
 
 
Depreciation-113.9M-104.5M-106.3M-109.1M
 
 
 
 
 
Intangible Assets773.8M1.1B1.1B1.1B
 
 
 
 
 
Other Assets773.8M1.1B1.1B1.1B
 
 
 
 
 
Total Assets1.2B1.6B1.6B1.6B
 
 
 
 
 
 
LiabilitiesAccounts Payable26.0M23.8M31.9M24.1M
 
 
 
 
 
Accrued Expenses14.5M18.8M17.7M21.6M
 
 
 
 
 
Other Current Liabilities22.4M26.6M25.4M27.6M
 
 
 
 
 
Other Liabilities102.2M108.0M113.3M108.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.3M258.0M273.3M263.4M
 
 
 
 
 
Deferred Taxes-57.3M-64.9M-88.9M-85.7M
 
 
 
 
 
Other Liabilities300.0K9.8M10.9M11.5M
 
 
 
 
 
Total Liabilities261.4M471.4M492.5M475.6M
 
 
 
 
 
 
EquityMinority Interest0.00-100.0K0.000.00
 
 
Preferred Stock0.000.000.000.00--
Common Equity964.9M1.1B1.1B1.1B
 
 
 
 
 
Total Shareholder Equity964.9M1.1B1.1B1.1B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding70.6M74.7M73.2M73.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.